
欧洲心血管针市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析(圆形针和切割针);应用(心脏直视手术和心脏瓣膜手术);使用(单次使用和多次使用);最终用户(医院和诊所、门诊手术中心和心血管中心)
No. of Pages: 119 | Report Code: TIPRE00025899 | Category: Life Sciences
No. of Pages: 119 | Report Code: TIPRE00025899 | Category: Life Sciences
心血管针用于多种心血管手术,如心脏直视手术、心脏瓣膜手术、心脏移植、冠状动脉搭桥手术等许多手术都需要手术针。这些心血管针有两种类型:一次性或无眼针和多次使用或有眼针。心血管针由含有高浓度镍、Surgalloy 和 Ethalloy 的新型不锈钢合金制成。
因此,心血管疾病患病率的不断上升预计将在未来对心血管针产生巨大的需求预计这将进一步推动心血管针市场的发展。
由于持续的冠状病毒,整个欧洲的心脏手术正在遭受挫折。手术被推迟,治疗被推迟,重症监护人员被重新部署,以应对 Covid-19 疫情对卫生服务的影响。有证据表明,美国和英国的心脏手术数量大幅下降。在英国,英国心脏基金会慈善机构对情况进行了监测,发现 2020 年进行了约 371,000 例心脏手术和手术,比 2019 年的 473,000 例减少了 22%。与 2019 年相比,到 2020 年 11 月底,冠状动脉搭桥和心脏瓣膜手术等手术从 37,000 例下降到约 25,000 例,而安装支架打开阻塞动脉等手术也有所下降。与此同时,在胸外科医生协会第 57 届年会上发表的研究表明,在美国,Covid-19 导致全国所有成人心脏手术减少 53%。英国公共卫生部门的数据显示,自疫情爆发以来,至少有 5,700 人因心脏病和中风死亡。心脏手术和程序的延误可能导致比预期更多的死亡。
欧洲心血管针市场预计将从2021年的24,408.5万美元增长到2028年的39,261.2万美元;预计 2021 年至 2028 年复合年增长率为 7.0%。由于生活方式的转变以及商业、工业和住宅基础设施的现代化,发展中国家心血管疾病的患病率显着上升;现代化的设施导致体力活动减少。另一方面,人们的压力水平继续上升。因此,这些因素正在推动发展中国家心血管疾病的流行。此外,这些国家正在大力发展其医疗保健设施和服务,并正在迈向技术进步。根据《柳叶刀》的全球疾病负担研究,约 10 人死亡与这种疾病有关,相当于约 640 万人死亡。因此,新兴国家为心血管针市场参与者提供了重大机遇;他们可以在预测期内以具有成本效益的产品进入这些尚未开发或较少开发的市场。
从类型来看,2020年欧洲心血管针市场中圆体针细分市场占据最大份额。从应用来看,心脏直视手术细分市场占据最大份额2020年欧洲心血管针市场的使用情况。就用途而言,一次性使用细分市场在2020年欧洲心血管针市场中占据最大份额。就最终用户而言,医院和诊所细分市场占据最大份额。 2020年欧洲心血管针市场。
准备本欧洲心血管针市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Ethicon (Johnson & Johnson Services, Inc.)、MANI, INC.、Barber of Sheffield、FSSB 手术针 GmbH、Medtronic、Teleflex Incorporated、Meril Life Sciences Pvt.。有限公司、CP Medical 和 SMB Corporation of India。
通过申请
按用途 span>
最终用户
按国家/地区< /p>
Strategic insights for Europe Cardiovascular Needle involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 24,408.5 thousand |
Market Size by 2028 | US$ 39,261.2 thousand |
Global CAGR (2021 - 2028) | 7.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Cardiovascular Needle refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Cardiovascular Needle Market is valued at US$ 24,408.5 thousand in 2021, it is projected to reach US$ 39,261.2 thousand by 2028.
As per our report Europe Cardiovascular Needle Market, the market size is valued at US$ 24,408.5 thousand in 2021, projecting it to reach US$ 39,261.2 thousand by 2028. This translates to a CAGR of approximately 7.0% during the forecast period.
The Europe Cardiovascular Needle Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cardiovascular Needle Market report:
The Europe Cardiovascular Needle Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Cardiovascular Needle Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Cardiovascular Needle Market value chain can benefit from the information contained in a comprehensive market report.